Most Recent
Legal community condemns Bondi terrorist attack, extends support
The Australian legal community has condemned a terror attack at a Bondi Beach Hanukkah celebration on Sunday, where 16 people were killed, and extended counseling services to its members. 
Gilbert + Tobin bolsters disputes practice with partner from Jones Day
Gilbert + Tobin has poached a litigation partner from Jones Day, strengthening the law firm's blue ribbon disputes practice.
TG Metals shareholder wins bid to inspect company’s books
A shareholder of gold and lithium exploration company TG metals has won its bid to inspect the company’s books over concerns about two capital raisings that occurred within six weeks of each other. 
SkyCity shareholder can’t bring action over $67M AUSTRAC penalty
A SkyCity shareholder has lost his bid to bring a case against former executives and directors at the ASX-listed casino seeking to recoup a $67 million penalty over breaches of money laundering regulations. 
Fortescue, Element Zero reach settlement in trade secrets case
After losing a fight over access to millions of seized documents, Fortescue has settled its trade secrets case against green iron company Element Zero.
Construction PRO
APAC shareholders must hand over silk, G+T advice in fight with Dexus
Real estate asset manager Dexus has won access to advice given by the lawyers of two shareholders of airport operator APAC over an alleged breach of a shareholder deed. 
Construction PRO
Court throws out native title appeal over AngloGold mining leases
An appeals court has confirmed that mining companies AngloGold and IGO Limited did not need to renegotiate native title approvals when they consolidated 31 existing mining leases into a single lease. 
Light & Wonder employees can’t dodge subpoenas in Aristocrat case
A judge has signed off on subpoenas compelling employees of gaming company Light & Wonder to give evidence in a US case by Aristocrat alleging misuse of confidential information about its popular Dragon Link poker machine.
Takeovers Panel says Cosette can’t shutter Mayne’s Adelaide drug plant
The Takeovers Panel has found Cosette cannot close a Mayne Pharma drug manufacturing plant in Adelaide, another win for Mayne in its push to block the US drug maker from walking away from their $672 million merger.
Mayne wins extension of FIRB deadline for Cosette takeover
The Foreign Investment Review Board has extended the deadline for ruling on Cosette's proposed $672 million takeover of Mayne Pharma.